CHIP FOR QUANTITATIVE DETECTION OF NEUTRALIZING ANTIBODY AND MANUFACTURING METHOD THEREOF
20240019428 ยท 2024-01-18
Inventors
Cpc classification
G01N33/54393
PHYSICS
International classification
Abstract
The present invention provides a detection chip for quantitative detection of neutralizing antibody and manufacturing method thereof. A sensing layer is disposed on a circuit layer. A shielding layer corresponds a shielding part on the sensing layer to form a sensing area. The surface of the sensing area is hydroxylated to form a self-assembled monolayer film including the aldehyde group. A protein solution is dripped on the sensing area. An external electric field is applied to the sensing layer at an external angle with respect to the normal of the substrate to deflect protein molecules in the protein solution correspondingly. This structure can be applied to rapid and quantitative detection. According to various embodiments of the present invention, the sensing efficiency of the detection chip can be enhanced.
Claims
1. A method for manufacturing a chip for quantitative detection of neutralizing antibody, applied to binding protein molecules in a protein solution, and said manufacturing method comprises steps of: dripping said protein solution to a chip for quantitative detection of neutralizing antibody, which chip is used to bind said protein molecules to a sensing area of said chip for quantitative detection of neutralizing antibody; and applying an external electric field to said chip for quantitative detection of neutralizing antibody at an external angle with respect to the normal of said chip for quantitative detection of neutralizing antibody and said external electric field deflecting said protein molecules corresponding to said external angle.
2. The method for manufacturing a chip for quantitative detection of neutralizing antibody of claim 1, and before said step of dripping said protein solution to a chip for quantitative detection of neutralizing antibody, which step is used to bind said protein molecules to a sensing area of said chip for quantitative detection of neutralizing antibody, further comprising steps of: hydroxylating said sensing area of said chip for quantitative detection of neutralizing antibody; and forming a self-assembled monolayer film including the aldehyde group for binding said protein molecules to said sensing area.
3. The method for manufacturing a chip for quantitative detection of neutralizing antibody of claim 1, and after hydroxylating the surfaces of said plurality of sensing areas and forming said self-assembled monolayer film, further forming a cross-linked molecular film on the self-assembled monolayer film.
4. The method for manufacturing a chip for quantitative detection of neutralizing antibody of claim 1, wherein the receptor binding domain of said protein molecules belongs to the superfamily and subfamily of CoV_Spike_S1_RBD.
5. The method for manufacturing a chip for quantitative detection of neutralizing antibody of claim 4, wherein said external angle with respect to the normal of said chip for quantitative detection of neutralizing antibody is between 15 and 15.
6. A chip for quantitative detection of neutralizing antibody, comprising: a substrate; a plurality of circuit layers, disposed on said substrate; a sensing layer, disposed on said substrate and on said plurality of circuit layers; and a shielding layer, disposed on said sensing layer and including an opening corresponding to said plurality of circuit layers, and said opening forming a sensing area on said sensing layer.
7. The chip for quantitative detection of neutralizing antibody of claim 6, and after hydroxylating the surface of said sensing area and forming a self-assembled monolayer film including the aldehyde group, dripping said protein solution to said sensing area and applying an external electric field to said sensing layer at an external angle with respect to the normal of said substrate for deflecting said protein molecules in said protein solution and binding with said self-assembled monolayer film.
8. The chip for quantitative detection of neutralizing antibody of claim 6, wherein the material of said shielding layer is selected from the group consisting of silicon mononitride and silicon oxynitride.
9. The chip for quantitative detection of neutralizing antibody of claim 7, and after hydroxylating the surfaces of said plurality of sensing areas and forming said self-assembled monolayer film, further forming a cross-linked molecular film on the self-assembled monolayer film.
10. The chip for quantitative detection of neutralizing antibody of claim 7, wherein the receptor binding domain of said protein molecules belongs to the superfamily and subfamily of CoV_Spike_S1_RBD.
11. The chip for quantitative detection of neutralizing antibody of claim 10, wherein said external angle with respect to the normal of said chip for quantitative detection of neutralizing antibody is between 15 and 15.
12. A chip for quantitative detection of neutralizing antibody, comprising: a substrate; a plurality of circuit layers, disposed on said substrate; a plurality of sensing layers, disposed on said plurality of circuit layers, respectively; and a shielding layer, disposed on said substrate, between said plurality of circuit layers, respectively, and on said plurality of sensing layers, including an opening corresponding to said plurality of circuit layers, respectively, and said opening forming a sensing area on said plurality of sensing layers, respectively.
13. The chip for quantitative detection of neutralizing antibody of claim 12, and after hydroxylating the surface of said plurality of sensing areas and forming a self-assembled monolayer film including the aldehyde group, dripping said protein solution to said plurality of sensing areas and applying an external electric field to said plurality of sensing areas at an external angle with respect to the normal of said substrate for deflecting said protein molecules in said protein solution and binding with said self-assembled monolayer film.
14. The chip for quantitative detection of neutralizing antibody of claim 12, wherein the material of said shielding layer is selected from the group consisting of silicon mononitride and silicon oxynitride.
15. The chip for quantitative detection of neutralizing antibody of claim 14, and after hydroxylating the surfaces of said plurality of sensing areas and forming said self-assembled monolayer film, further forming a cross-linked molecular film on the self-assembled monolayer film.
16. The chip for quantitative detection of neutralizing antibody of claim 13, wherein the receptor binding domain of said protein molecules belongs to the superfamily and subfamily of CoV_Spike_S1_RBD.
17. The chip for quantitative detection of neutralizing antibody of claim 16, wherein said external angle with respect to the normal of said chip for quantitative detection of neutralizing antibody is between 15 and 15.
18. A chip for quantitative detection of neutralizing antibody, comprising: a substrate; a plurality of circuit layers, disposed on said substrate; a plurality of sensing layers, covering the outer side of said plurality of circuit layers, respectively; and a shielding layer, disposed on said substrate and between said plurality of circuit layers to form a plurality of sensing areas on said plurality of sensing layers.
19. The chip for quantitative detection of neutralizing antibody of claim 18, and after hydroxylating the surface of said plurality of sensing areas and forming a self-assembled monolayer film including the aldehyde group, dripping said protein solution to said plurality of sensing areas and applying an external electric field to said plurality of sensing areas at an external angle with respect to the normal of said substrate for deflecting said protein molecules in said protein solution and binding with said self-assembled monolayer film.
20. The chip for quantitative detection of neutralizing antibody of claim 19, and after hydroxylating the surfaces of said plurality of sensing areas and forming said self-assembled monolayer film, further forming a cross-linked molecular film on the self-assembled monolayer film.
21. The chip for quantitative detection of neutralizing antibody of claim 18, wherein the material of said shielding layer is selected from the group consisting of silicon mononitride and silicon oxynitride.
22. The chip for quantitative detection of neutralizing antibody of claim 19, wherein the receptor binding domain of said protein molecules belongs to the superfamily and subfamily of CoV_Spike_S1_RBD.
23. The chip for quantitative detection of neutralizing antibody of claim 22, wherein said external angle with respect to the normal of said chip for quantitative detection of neutralizing antibody is between 15 and 15.
24. A chip for quantitative detection of neutralizing antibody, comprising: a substrate; a shielding layer, disposed on said substrate; a plurality of circuit layers, disposed on said shielding layer; and a plurality of sensing layers, covering the outer side of said plurality of circuit layers, respectively, to form a plurality of sensing areas on said plurality of sensing layers.
25. The chip for quantitative detection of neutralizing antibody of claim 24, and after hydroxylating the surface of said plurality of sensing areas and forming a self-assembled monolayer film including the aldehyde group, dripping said protein solution to said plurality of sensing areas and applying an external electric field to said plurality of sensing areas at an external angle with respect to the normal of said substrate for deflecting said protein molecules in said protein solution and binding with said self-assembled monolayer film.
26. The chip for quantitative detection of neutralizing antibody of claim 24, wherein the material of said shielding layer is selected from the group consisting of silicon mononitride and silicon oxynitride.
27. The chip for quantitative detection of neutralizing antibody of claim 25, and after hydroxylating the surfaces of said plurality of sensing areas and forming said self-assembled monolayer film, further forming a cross-linked molecular film on the self-assembled monolayer film.
28. The chip for quantitative detection of neutralizing antibody of claim 25, wherein the receptor binding domain of said protein molecules belongs to the superfamily and subfamily of CoV_Spike_S1_RBD.
29. The chip for quantitative detection of neutralizing antibody of claim 28, wherein said external angle with respect to the normal of said chip for quantitative detection of neutralizing antibody is between 15 and 15.
Description
BRIEF DESCRIPTION OF THE DRAWINGS
[0021]
[0022]
[0023]
[0024]
[0025]
[0026]
[0027]
[0028]
[0029]
[0030]
[0031]
[0032]
[0033]
[0034]
DETAILED DESCRIPTION
[0035] In order to make the structure and characteristics as well as the effectiveness of the present invention to be further understood and recognized, the detailed description of the present invention is provided as follows along with embodiments and accompanying figures.
[0036] To solve the technical problems according to the prior art as described above, according to the present invention, a shielding layer is disposed on a sensing layer for shielding a part of the sensing layer correspondingly. The shielding layer includes an opening corresponding to the circuit layer. A sensing area is formed on the sensing layer corresponding to the opening. The sensing area is used to bind protein molecules on the sensing layer for detecting the target ligands. According to the present invention, the shielding layer is further disposed between a plurality of circuit layers and a substrate for partitioning the sensing areas on the sensing layer for detecting the target ligands.
[0037] Please refer to
[0040] According to the present embodiment, the protein molecules in the protein solution further include spike proteins of coronaviruses with receptor binding domain belonging to the superfamily and subfamily of CoV_Spike_S1_RBD and the National Center for Biotechnology Information (NCBI) registration number c140478.
[0041] Please refer to
[0042] Please refer to
[0043] Please refer to
[0046] In the step S11, the detection chip 1 includes a sensing area. In addition, before dripping the protein solution, the sensing area of the detection chip 1 is hydroxylated. In the step S12, a self-assembled monolayer film including the aldehyde group is formed on the sensing area of the detection chip 1. Afterwards, the steps S01 and S02 are executed to form covalent bonds between the protein molecules in the protein solution and the self-assembled monolayer film. Then the external electric filed E is used to align the protein molecules to the same external angle before fixing the protein molecules to the self-assembled monolayer film in the optimum exposed direction of receptor binding domain.
[0047] According to the present embodiment, oxygen plasma is used to process the chip for quantitative detection of neutralizing antibody and hydroxylate the surface thereof. Alternatively, the piranha solution can be used to immerse the chip for quantitative detection of neutralizing antibody and hydroxylate the surface thereof.
[0048] According to the present embodiment, triethoxysilylundecanal (TESUA) is used to form a self-assembled monolayer film including the aldehyde group on the chip for quantitative detection of neutralizing antibody.
[0049] Please refer to
[0050] Please refer to
[0051] Please refer again to
[0052] According to the present embodiment, according to the present embodiment, the protein molecules 2 then bind with the target ligands to be detected. By limiting the locations of the hydroxyl group 50 and the protein molecules 2, the binding efficiency between the protein molecules and the target ligands to be detected can be enhanced and thus achieving the efficacy of quantitative detecting target ligands.
[0053] According to the present embodiment, according to the present embodiment, as shown in
[0054] According to the present embodiment, according to the present embodiment, a plurality of hydroxyl groups 50 and a plurality of protein molecules 2 are disposed in the sensing areas 32 of the sensing layer 30. Nonetheless, the present invention is not limited to the present embodiment.
[0055] According to the present embodiment, according to the present embodiment, the material of the plurality of sensing layers 30 is selected from the group consisting of SiO.sub.2, NdAlO.sub.3, Al.sub.2O.sub.3, PrAlO.sub.3, HfO.sub.2, SmAlO.sub.3, BeAl.sub.2O.sub.4, SrTiO.sub.3, (Ba,Sr)TiO.sub.3, Ta.sub.2O.sub.5, CeO.sub.2, TiO.sub.2, La.sub.2O.sub.3, Y.sub.2O.sub.3, LaAlO.sub.3, ZrO.sub.2, and LaScO.sub.3. Nonetheless, the present invention is not limited to the present embodiment.
[0056] According to the present embodiment, according to the present embodiment, the material of the shielding layer 40 is selected from the group consisting of SiNx, TiN, CxFy, TaN, SiC, AlN, CHx (hydrogen carbides), -Si, -Ge, -Carbon, BN, and CNx (nitrogen carbides). Nonetheless, the present invention is not limited to the present embodiment. These materials can avoid the hydroxyl group 50 from being disposed on the surface of the shielding layer 40, which will further cause the chip 1 for quantitative detection of neutralizing antibody to generate false signals.
[0057] Please refer to
[0058] Please refer to
[0059] Please refer to
[0060] The difference between the present embodiment and the first embodiment as described above is that, according to the present embodiment, the plurality of sensing layers 30 are disposed on the corresponding circuit layers 20 only, and the shielding layer 40 covers the substrate 10 and the side surfaces between the plurality of circuit layers 20 for further shrinking the size of the chip 1 for quantitative detection of neutralizing antibody and reducing waste of materials.
[0061] Please refer again to
[0062] According to the present embodiment, according to the present embodiment, the protein molecules 2 then bind with the target ligands to be detected. By limiting the locations of the hydroxyl group 50 and the protein molecules 2, the binding efficiency between the protein molecules and the target ligands to be detected can be enhanced and thus achieving the efficacy of quantitative detecting target ligands.
[0063] According to the present embodiment, according to the present embodiment, as shown in
[0064] According to the present embodiment, according to the present embodiment, a plurality of hydroxyl groups 50 and a plurality of protein molecules 2 are disposed in the sensing areas 32 of the sensing layer 30. Nonetheless, the present invention is not limited to the present embodiment.
[0065] According to the present embodiment, according to the present embodiment, the plurality of sensing layers 30 and the shielding layer 40 are the same as the above embodiment. The materials of the shielding layer 40 can avoid the hydroxyl group 50 from being disposed on the surface of the shielding layer 40, which will further cause the chip 1 for quantitative detection of neutralizing antibody to generate false signals.
[0066] Please refer to
[0067] Please refer to
[0068] The difference between the present embodiment and the first embodiment as described above is that, according to the present embodiment, the shielding layer 40 covers the surfaces between the plurality of sensing layers 30, respectively, for simplifying the manufacturing steps for the detection chip and further lowering the manufacturing cost for the chip 1 for quantitative detection of neutralizing antibody.
[0069] Please refer again to
[0070] According to the present embodiment, according to the present embodiment, the protein molecules 2 then bind with the target ligands to be detected. By limiting the locations of the hydroxyl group 50 and the protein molecules 2, the binding efficiency between the protein molecules and the target ligands to be detected can be enhanced and thus achieving the efficacy of quantitative detecting target ligands.
[0071] According to the present embodiment, according to the present embodiment, as shown in
[0072] According to the present embodiment, according to the present embodiment, a plurality of hydroxyl groups 50 and a plurality of protein molecules 2 are disposed in the sensing areas 32 of the sensing layer 30. Nonetheless, the present invention is not limited to the present embodiment.
[0073] According to the present embodiment, according to the present embodiment, the plurality of sensing layers 30 and the shielding layer 40 are the same as the above embodiment. The materials of the shielding layer 40 can avoid the hydroxyl group 50 from being disposed on the surface of the shielding layer 40, which will further cause the chip 1 for quantitative detection of neutralizing antibody to generate false signals.
[0074] Please refer to
[0075] Please refer to
[0076] The difference between the present embodiment and the first embodiment as described above is that, according to the present embodiment, the shielding layer 40 is disposed between the substrate 10 and the plurality of circuit layers 20 for further simplifying the manufacturing steps for the detection chip and lowering the manufacturing cost for the chip 1 for quantitative detection of neutralizing antibody.
[0077] Please refer again to
[0078] According to the present embodiment, according to the present embodiment, the protein molecules 2 then bind with the target ligands to be detected. By limiting the locations of the hydroxyl group 50 and the protein molecules 2, the binding efficiency between the protein molecules and the target ligands to be detected can be enhanced and thus achieving the efficacy of quantitative detecting target ligands.
[0079] According to the present embodiment, according to the present embodiment, as shown in
[0080] According to the present embodiment, according to the present embodiment, a plurality of hydroxyl groups 50 and a plurality of protein molecules 2 are disposed in the sensing areas 32 of the sensing layer 30. Nonetheless, the present invention is not limited to the present embodiment.
[0081] According to the present embodiment, according to the present embodiment, the plurality of sensing layers 30 and the shielding layer 40 are the same as the above embodiment. These materials of the shielding layer 40 can avoid the hydroxyl group 50 from being disposed on the surface of the shielding layer 40, which will further cause the chip 1 for quantitative detection of neutralizing antibody to generate false signals.
[0082] Please refer to
[0083] To sum up, the present invention provides a chip for quantitative detection of neutralizing antibody and the manufacturing method thereof. A sensing layer is disposed on a circuit layer. Then a shielding layer shields a part of the sensing layer. The shield layer includes an opening corresponding to the circuit layer to expose a part of the sensing layer and forming a sensing area. The sensing area includes the hydroxyl group for further binding with protein molecules and sensing the target ligands to be detected. The shielding layer is used to limit the region on the sensing layer to bind the hydroxyl group, stabilize the signal generated by the sensing layer, and limit the locations of the hydroxyl group and protein molecules. In addition, by using the angle 1515 of the external electric field with respect to the substrate, protein molecules are fixed to the chip for quantitative detection of neutralizing antibody (for example, the unknown antibody induced by the COVID-19 virus or vaccine), so that the chip for quantitative detection of neutralizing antibody can quantitatively detecting the concentration of the target ligands. The present invention solves the problem of random orientation of protein molecules on the detection chip in the process of fixing protein molecules to the detection chip according to the prior art. The random orientation lowers the binding efficiency between the protein molecules and the target ligands to be detected and deteriorates the detection efficiency of the detection chip for neutralizing antibody.
[0084] Accordingly, the present invention conforms to the legal requirements owing to its novelty, nonobviousness, and utility. However, the foregoing description is only embodiments of the present invention, not used to limit the scope and range of the present invention. Those equivalent changes or modifications made according to the shape, structure, feature, or spirit described in the claims of the present invention are included in the appended claims of the present invention.